#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uterine leiomyosarcoma Metastatic gastric cancer Chronic cutaneous lupus erythematosus Neuroendocrine tumour Hypergammaglobulinaemia benign monoclonal Autologous haematopoietic stem cell transplant Hairy cell leukaemia recurrent Rheumatoid arthritis Encephalitis autoimmune Langerhans' cell histiocytosis Cytokine release syndrome B-cell small lymphocytic lymphoma Squamous cell carcinoma of the hypopharynx Acquired ATTR amyloidosis Aicardi-Goutieres syndrome More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Diagnostics Synovial sarcoma metastatic Glycogen storage disease type V – Trials in Disease Netherton’s syndrome – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Rhabdoid tumour Friedreich’s ataxia – Diagnostics Toxic epidermal necrolysis Behcet’s syndrome Angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tigecycline Pyridoxine Hydrochloride Clomipramine Hydrochloride 68Ga-Dpi-4452 Tenecteplase Dasatinib Crd-4730 SOFOSBUVIR Azd5492 Tocilizumab Digoxin Immune Fab (Ovine) Benzathine Benzylpenicillin Mitotane Teriparatide LIPASE Follitropin Alfa Cpk850 TRV045 N-Tec Crizanlizumab More therapies…

    Learn about Your Condition

    Stem cell transplant Renal cell carcinoma Follicular lymphoma Impaired gastric emptying Normal pressure hydrocephalus Incontinence Mechanical ventilation Penile cancer Acute cardiac event Herpes simplex reactivation Suicidal ideation Cataract Synovitis Acne Diabetic nephropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of daridorexant and buprenorphine combination treatment for patients with opioid use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Buprenorphine
    • Naloxone
    • Daridorexant
    Sweden

  • Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Osimertinib
    • Datopotamab Deruxtecan
    France Germany Italy Poland Spain

  • Study of Durvalumab for Patients with Early Stage or Locally Advanced Non-Small Cell Lung Cancer Not Suitable for Surgery

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Portugal

  • Study on the Diagnostic Performance of 68Ga-ABS011 PET/CT for Patients with Metastatic Breast Cancer

    Recruiting

    4 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • 68Ga-Nota-Abscint-Her2
    Austria Belgium

  • Study on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer’s, Parkinson’s, or ALS Using Dronabinol and Cannabidiol

    Recruiting

    2 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    • Dementia Alzheimer’s type
    • Parkinson’s disease
    Investigated Drugs:
    • Cannabidiol
    • Dronabinol
    Italy

  • Study on Aldesleukin and Dendritic Cell Vaccine for Patients with Resected Stage IV Neuroendocrine Tumors and Soft Tissue Sarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Soft tissue sarcoma
    Investigated Drugs:
    • Autologous Tumor Lysate-Loaded Dendritic Cells
    • Aldesleukin
    Italy
Previous Page
1 … 312 313 314 315 316 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!